Please login to the form below

Not currently logged in
Email:
Password:

genital herpes

This page shows the latest genital herpes news and features for those working in and with pharma, biotech and healthcare.

Genital herpes vaccine candidate promising in phase II

Genital herpes vaccine candidate promising in phase II

A vaccine that could free patients with genital herpes from lifelong drug treatment to control outbreaks has shown promise in a phase II trial. ... The vaccine - called GEN-003 and developed by Genocea Biosciences - is a T cell-enabled therapeutic

Latest news

  • Vical's genital herpes vaccine flunks trial Vical's genital herpes vaccine flunks trial

    Vical admitted yesterday that two versions of its genital herpes vaccine failed to meet their objectives in a phase III trial, throwing the future of the programme into doubt. ... to reduce virus shedding in patients with genital herpes in the phase I/II

  • Sanofi to work with Immune Design on herpes vaccine Sanofi to work with Immune Design on herpes vaccine

    Sanofi has joined forces with US biotech Immune Design to accelerate development of the first therapeutic vaccine against genital herpes. ... Sanofi notes that genital herpes is the most common STI and affects around one in six people in the US, with

  • Medivir and Meda in Xerese renegotiation

    Medivir has renegotiated the terms of its financial arrangement with Meda for Xerese, its marketed product for herpes labialis, in North America. ... The agreement also provides Meda with the exclusive US rights to Xerese for the genital herpes indication

  • FDA cracks down on bogus STD drugs

    The two federal agencies are targeting products that make unproven claims to treat, cure, and prevent STDs including herpes, chlamydia, genital warts, HIV and AIDS. ... and proven herpes killers in a single formula"; and Viruxo, which is sold on a

  • Valeant acquires GSK's Zovirax

    Valeant Pharmaceuticals' Biovail Laboratories has signed a deal under which it will acquire all US and Canadian rights to non-ophthalmic topical formulations of GlaxoSmithKline's (GSK) herpes drug Zovirax (acyclovir) ... Zovirax ointment and cream are

More from news
Approximately 1 fully matching, plus 9 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Dovetail

About Dovetail We’re award-winning specialists in healthcare collaboration that makes patients’ lives better. Combining expertise with a passion for collaboration,...

Latest intelligence

DNA
Why precision medicine demands precision engagement
The speed of innovation brings its own challenges, says cloud computing expert...
Unlocking the potential of science and technology in the UK
Greater collaboration is vital in post-Brexit UK, says Alderley Park leader...
NHS regional footprints
What to expect from 2019...

Infographics